Scott Kellen, CFO and Secretary at DiaMedica Therapeutics Inc. (DMAC), bought 4,000 shares at $2.94 ($12K) on 2019-05-24, disclosed to the SEC on 2019-05-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| DMAC | BUY | 2020-11-10 | $8K | — | Filing → |
| DMAC | BUY | 2019-08-19 | $7K | — | Filing → |
| DMAC | BUY | 2018-12-11 | $5K | — | Filing → |